Tardive dyskinesia due to risperidone

European Psychiatry

Volumn 13, Issue 2, 1998, Pages 107-108

  Sakkas, P ^a   Liappas, J ^a   Christodoulou, G N ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CARBIDOPA PLUS LEVODOPA; FLUOXETINE; GAMMA GLUTAMYLTRANSFERASE; LEVOMEPROMAZINE; MIANSERIN; RISPERIDONE; TRIFLUOPERAZINE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOSIS; TARDIVE DYSKINESIA;

EID: 0031950404     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(98)80028-X     Document Type: Article

References (10)

1. 1 Addington DE, Toews JA, Addington JM. Risperidone and tardive dyskinesia. J Clin Psychiatry 1995 ; 56 : 484-5
2. 2 Buzan RD. Risperidone induced tardive dyskinesia. Am J Psychiatry 1996 ; 153 : 734-5
3. 3 Chouinard G. Effects of risperidone in tardive dyskinesia: an analysis of the Canadian multicenter risperidone study. J Clin Psychopharmacol 1995 ; 15 suppl 1 : 36S-44S
4. 4 Coulter DM, Pillans PI. Fluoxetine and extrapyramidal side effects. Am J Psychiatry 1995 ; 152 : 122-5
5. 5 Daniel DG, Smith K, Hyde T, Egan M. Neuroleptic-induced tardive dyskinesia. Am J Psychiatry 1996 ; 153 : 734
6. 6 Gardos G, Cole JO, Salomon M, Schniebolk S. Clinical forms of severe tardive dyskinesia. Am J Psychiatry 1987 ; 144 : 895-902
7. 7 Kopala LC, Honer WG. Schizophrenia and severe tardive dyskinesia responsive to risperidone. J Clin Psychopharmacol 1994 ; 14 : 430-1
8. 8 Nyberg S, Farde L, Eriksson L, Halldin C, Eriksson B. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. Psychopharmacology 1993 ; 110 : 265-72
9. 9 Rangwani SR, Gupta S, Burke WJ, Potter J. Improvement of debilitating tardive dyskinesia with risperidone. Ann Clin Psychiatry 1996 ; 8 : 27-9
10. 10 Woerner MG, Sheitman BB, Lieberman JA, Kane JM. Tardive dyskinesia induced by risperidone? Am J Psychiatry 1996 ; 153 : 843